Dyadic Logo Current.jpg
Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform
December 17, 2021 07:00 ET | Dyadic International, Inc.
JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
ZEUS Scientific Acquires Synthetic Peptides from Sheba Medical Center's Tech Transfer Co.
October 29, 2021 08:30 ET | ZEUS Scientific
BRANCHBURG, N.J., Oct. 29, 2021 (GLOBE NEWSWIRE) -- ZEUS Scientific has obtained exclusive, worldwide rights to the use of these synthetic peptides as targets of disease-specific autoantibodies in...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
July 20, 2021 09:00 ET | Sorrento Therapeutics, Inc.
China National Medical Product Administration (NMPA) has granted Mabpharm approval to market INFLIXIMAB biobetter in China.Sorrento holds commercialization rights outside of China and intends to meet...
I Have Ankle Arthritis – Now What? Rosemont, Ill., May 27, 2021 (GLOBE NEWSWIRE) -- May is National Arthritis Awareness Month, a time to bring attention to a disease that affects one in four adults in the United States. Arthritis can...
Nurix.png
Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress
May 21, 2021 07:00 ET | Nurix Therapeutics, Inc.
SAN FRANCISCO, May 21, 2021 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that preclinical...
CWHP_Logo_Horizontal.jpg
The Center for Workforce Health and Performance and National Association of Worksite Health Centers Release Report to Help Employers and Insurers Manage Musculoskeletal Conditions
April 22, 2021 08:03 ET | The Center for Workforce Health and Performance
OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are estimated to cost insurers and employers about $6.3 billion...
“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During September’s Rheumatic Disease Awareness Month
September 02, 2020 11:29 ET | American College of Rheumatology
ATLANTA, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and Simple Tasks™ will recognize the fifth annual Rheumatic Disease Awareness Month (RDAM) this September with...
Premium Hemp CBD manufacturer Tree of Life Seeds partners with the Arthritis Foundation
October 22, 2019 11:16 ET | Arkansas Arthritis Foundation
Little Rock, Arkansas, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The Arkansas Arthritis Foundation is partnering with Tree of Life Seeds, Arkansas-based hemp genetics and CBD product manufacturer, to raise...
Allsup Supports U.S. Pain Foundation in Bringing Attention to Chronic Pain during National Pain Awareness Month
September 23, 2019 11:57 ET | Allsup
Belleville, Illinois, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Allsup, the nation’s premier disability representation company, remains committed to supporting the significant contributions of the U.S....
Sandoz Canada receives Health Canada approval for Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis (PsA) in Adult Patients
January 21, 2019 08:31 ET | Sandoz Canada
Boucherville, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic arthritis (PsA) in adult patients.Up to...